About this trial
Transit-time flowmetry (TTFM) allows grafts quality control during coronary artery bypass surgery by measuring the flow volume through them.
To date, many studies have deeply studied the predictive role on the graft outcomes of the various flowmetry-derived parameters. One of the least investigated aspects, however, is the mutual influence that two newly realized grafts can have. This possibility would be related to the presence of a more or less developed collateral circulation between the bypassed territories.
The purpose of this study is to assess whether a graft for a territory different than that provided by the left anterior descending artery (LAD) may affect the functionality (measured through flowmetry) of the left internal mammary artery - LAD graft.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
age > 18 years;
informed consent acquired and registered;
patients who undergo coronary artery bypass grafting (with or without cardiopulmonary bypass);
patients with stable angina, unstable angina or acute coronary syndrome without elevation of the ST tract (NSTEMI)
Disqualifiers
patients unable to give informed consent;
patients undergoing emergency surgery;
patients in unstable haemodynamic conditions or in need of pharmacological or mechanical support;
patients undergoing combined surgery;
Trial population
All patients with coronary artery disease and an indication for surgical revascularization (coronary artery bypass grafting) who meet the above-described inclusion and exclusion criteria will be enrolled by signing the informed consent the day before surgery.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
LIMA>LAD Pulsatility index (PI) modification
The primary aim of this study is to assess whether a graft for a non-LAD coronary target modifies the performance (measured by flowmetry) of the flow in the LIMA\>LAD graft. PI is expressed by the ratio of the flow volume amplitude and mean flow volume, both quantified by a flowmeter (ml/min / ml/min). An ideal value would be \< 3
Secondary outcomes
LIMA>LAD mean flow change
under rest conditions and after pharmacological stress. The unit of measure will be ml/min. The average flow should be above 20 ml/min.
LIMA>LAD Diastolic filling (%DF) change
under rest conditions and after pharmacological stress. The unit of measure will be the ratio between two parameters expressed by ml/min.
variation of Diastolic filling (%DF) on the right coronary
depending on its dominance or hyperdominance. The unit of measure will be the ratio between two parameters expressed by ml/min. DF% is accepted around 50%.
LIMA>LAD % Backward flow (BF) change
under rest conditions and after pharmacological stress. The unit of measure will be the ratio between two parameters expressed by ml/min. The identified cut-off is 3% of the total flow.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: